Blank Check Co.'s Goodwin-Led $118M IPO Employs Odd Tact
Shares for Therapeutics Acquisition Corp., a blank check company targeting biotechnology enterprises in the health care industry, began trading Wednesday in an upsized $118 million initial public offering advised on by...To view the full article, register now.
Already a subscriber? Click here to view full article